The Current Ratio as of December 2024 (TTM) for Haemonetics Corporation (HAE) is 3.49

According to Haemonetics Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 3.49. This represents a change of 9.61% compared to the average of 3.18 of the last 4 quarters.

Haemonetics Corporation (HAE) Historical Current Ratio (quarterly & annually)

How has HAE Current Ratio performed in the past?

The mean historical Current Ratio of Haemonetics Corporation over the last ten years is 2.40. The current 3.49 Current Ratio has changed 14.41% with respect to the historical average. Over the past ten years (40 quarters), HAE's Current Ratio was at its highest in in the July 2022 quarter at 3.81. The Current Ratio was at its lowest in in the March 2018 quarter at 1.35.

Haemonetics Corporation (HAE) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Haemonetics Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Haemonetics Corporation (HAE) Average Current Ratio

How has HAE Current Ratio performed in the past?

The current Current Ratio of Haemonetics Corporation (HAE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Haemonetics Corporation (HAE) Current Ratio vs. Peers

How is HAE’s Current Ratio compared to its peers?

Haemonetics Corporation’s Current Ratio is less than Merit Medical Systems, Inc. (5.36), greater than AngioDynamics, Inc. (2.25), greater than AptarGroup, Inc. (1.62), greater than Envista Holdings Corp (2.08), less than Hologic, Inc. (3.69), greater than ICU Medical, Inc. (2.29), greater than The Cooper Companies, Inc. (1.91), greater than Teleflex Incorporated (2.42), greater than West Pharmaceutical Services, Inc. (3.00), greater than Alcon Inc. (0), greater than ResMed Inc. (2.92), greater than Akoya Biosciences, Inc. (2.75), less than AtriCure, Inc. (3.62), less than Atrion Corporation (6.80),

Build a custom stock screener for Haemonetics Corporation (HAE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Haemonetics Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Haemonetics Corporation (HAE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Haemonetics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.